Biovail

Valeant Pharmaceuticals; Market Cap: $25.73bn (as of 13/11/2015)   Introduction Valeant Pharmaceutical, a pharma behemoth renowned for its aggressive acquisition strategy, has been facing some hard times as its stellar performance has deteriorated considerably amid scrutiny over its monopoly pricing for its drugs as well as recent accusations for its Read more…